Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03493243
Other study ID # AVAL (29BRC17.0248)
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 14, 2018
Est. completion date April 13, 2018

Study information

Verified date October 2019
Source University Hospital, Brest
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

- Context: Since March 2012, several terrorist attacks have been perpetrated in France (Toulouse, Montauban, Paris, Nice ...). In March 2017, 53 french teenagers were victims in a terrorist attack in London (Westminster Bridge).

- Main goal = to estimate the psycho-traumatic impact and to describe cares and management of high school students, victims of the terrorist attack in London on 2017, March the 22nd.

- 3 secondary objectives: 1) Clinical (occurrence of Post Traumatic Stress Disorders or other disorders); 2) Epidemiological (risk factors for developing disorders, avoiding care); 3) Preventive and therapeutic.


Description:

Inclusion criterion: 53 teenagers of Saint-Joseph high school (Concarneau, France) directly exposed to the terrorist attack.

Methodology: self questionnaires and heterogenous questionnaires; descriptive statistics (means +/- standard deviations; search for a significant difference according to traumatic symptomatology)


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date April 13, 2018
Est. primary completion date April 13, 2018
Accepts healthy volunteers No
Gender All
Age group 14 Years to 20 Years
Eligibility Inclusion Criteria:

- 53 teenagers, from Concarneau (France) high school, directly exposed from London terrorist attack (22.03.2017).

Exclusion Criteria:

- All persons not directly exposed;

- Relatives of teenagers;

- 3 physically injured teenagers.

Study Design


Intervention

Other:
Questionnaires
2-hour clinical observation

Locations

Country Name City State
France CHU Brest
France HIA Hôpital d'Instruction des Armées Clermont Tonnerre Brest

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Brest

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary PTSD Post Traumatic Stress Disorder (Self-Questionnaire :Posttraumatic stress disorder checklist 5 ) One year after the terrorist attack (Day 1)
Secondary Clinical (occurence of Post Traumatic Stress Disorders or other disorders) Mini International Neuro-psychiatric Interview for children and adolescent One year after the terrorist attack (Day 1)
Secondary Epidemiological (risk factors for developing disorders, avoiding care); LEC = Life Event checklist One year after the terrorist attack (Day 1)
Secondary Preventive and therapeutic MINI = Mini International Neuropsychiatric Interview One year after the terrorist attack (Day 1)
Secondary Epidemiological (risk factors for developing disorders, avoiding care); ALCES = Adolescent Life Change Event Scale One year after the terrorist attack (Day 1)
Secondary Epidemiological (risk factors for developing disorders, avoiding care); EPS 10 = "Echelle de Provisions Sociales Abrégées"; One year after the terrorist attack (Day 1)
Secondary Epidemiological (risk factors for developing disorders, avoiding care); Whodas 2.0 = World Health Organization Disability Assessment Schedule One year after the terrorist attack (Day 1)
Secondary Preventive and therapeutic Questionnaire about use of psychoactive substances One year after the terrorist attack (Day 1)
See also
  Status Clinical Trial Phase
Recruiting NCT05915013 - Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response Phase 1
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Recruiting NCT05934162 - Efficacy of Internet-delivered Cognitive-behavior Therapy for PTSD N/A
Recruiting NCT05934175 - Intensive Treatment Versus Standard Weekly Prolonged Exposure for Adults With Post-Traumatic Stress Disorder N/A
Completed NCT04460014 - Simple Cognitive Task Intervention After Trauma During COVID-19 In Hospital Staff EKUT-P RCT N/A
Completed NCT05877807 - Effect of Baclofen to Prevent Post-Traumatic Stress Disorder
Active, not recruiting NCT05992649 - The Effect of Aquatic Physiotherapy on Veterans Suffering From PTSD - a 40-week Pilotproject N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Not yet recruiting NCT05331534 - Effect of Attentional Therapy on Post-traumatic Stress Disorder N/A
Not yet recruiting NCT03649607 - Accelerated Resolution Therapy for HIV Positive African, Caribbean and Black N/A
Not yet recruiting NCT04076215 - Biochemical and Physiological Response to Stressogenic Stimuli N/A
Not yet recruiting NCT02545192 - A Pilot Study of Low Field Magnetic Stimulation in PTSD: Three Daily Treatments Phase 1
Completed NCT02329418 - Written Document to Assist Family During Decision of Withholding and Withdrawing Life-sustaining Therapies in the Intensive Care Unit N/A
Active, not recruiting NCT00978484 - A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Phase 3
Completed NCT00760734 - Hyperbaric Oxygen Therapy (HBOT) in Chronic Traumatic Brain Injury (TBI)/Post Concussion Syndrome (PCS) and TBI/Post-Traumatic Stress Disorder (PTSD) Phase 1
Completed NCT03278171 - Early Detection of Patients at Risk of Developing a Post-traumatic Stress Disorder After a Stay in Intensive Care Unit
Recruiting NCT05874362 - People Bereaved by Violent Death : Negative Event Biases and Temporal Perception N/A
Terminated NCT03898843 - Assisted Animal Therapy: ReAnimal N/A
Recruiting NCT04747379 - Psychological Effect of Explicit Recall After Sedation (PEERS)
Completed NCT03248167 - Cannabidiol as a Treatment for AUD Comorbid With PTSD Phase 1/Phase 2